THE WOODLANDS, Texas (AP) — THE WOODLANDS, Texas (AP) — Lexicon Pharmaceuticals Inc. (LXRX) on Thursday reported a loss of $12.8 million in its third quarter.
On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 4 cents.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.
The drugmaker posted revenue of $14.2 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LXRX at https://www.zacks.com/ap/LXRX
/Amazon%20-%20Image%20by%20bluestork%20via%20Shutterstock.jpg)
/Apple%20Inc%20logo%20on%20Apple%20store-by%20PhillDanze%20via%20iStock.jpg)
/A%20Palantir%20sign%20displayed%20on%20an%20office%20building%20by%20Poetra_RH%20via%20Shutterstock.jpg)
